Get the latest tech news
Moderna reports first positive Phase 3 for mRNA neoantigen therapy in melanoma
Today marks an important milestone for @moderna_tx , for the field of mRNA, and for the many people working to bring new possibilities to patients. This morning, Moderna and Merck announced positive Phase 3 results for adjuvant treatment with intismeran autogene, an
None
Or read this on Hacker News
